v3.26.1
Earnings or Loss Per Share - Potential Diluted Effect of Diluted Loss Per Share (Details)
shares in Millions
1 Months Ended 6 Months Ended
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2026
$ / shares
shares
Jun. 30, 2025
shares
Outstanding options, SARs and RSUs (i)      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares)   65.2 46.1
Outstanding options, SARs and RSUs (i) | LILA Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares) 19.2    
Conversion ratio 1.43    
Weighted average exercise price (in dollars per share) | $ / shares $ 6.89 $ 6.89  
Outstanding options, SARs and RSUs (i) | LILAK Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares) 39.2    
Weighted average exercise price (in dollars per share) | $ / shares $ 6.73 $ 6.73  
Outstanding PSUs and PSARs (i)      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares)   11.8 8.6
Outstanding PSUs and PSARs (i) | LILA Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares) 3.9    
Weighted average exercise price (in dollars per share) | $ / shares $ 9.69 $ 9.69  
Outstanding PSUs and PSARs (i) | LILAK Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares) 7.9    
Conversion ratio 1.47    
Weighted average exercise price (in dollars per share) | $ / shares $ 9.49 $ 9.49  
LTVP and ESPP      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Securities excluded (in shares)   6.7 8.2